Vyvanse Cost, Coupon & FDA Approval Status (2026)
FDA Regulatory Database

Is Vyvanse
FDA approved?

DrugStatusIndex.com provides a plain-English status page for Vyvanse, including FDA approval status, prescription classification, compounding context, pricing information, and regulatory notes.

Needs FDA status review
FDA status
High-priority pricing page candidate
Drug category
May 2026
Last reviewed
Drug status summary

Vyvanse

Needs FDA status review

Vyvanse is included as a DrugStatusIndex high-priority pricing and FDA-status review entry.

Brand names
Vyvanse; lisdexamfetamine
Prescription status
Prescription status should be verified against current FDA labeling and pharmacy availability.
Compounded status
Verify approved products, generic availability, and lawful compounding status before publishing.
Confusion level
High
FDA Approved Approved for commercial use in the US
Not Approved Not cleared by FDA for use
Investigational Under review or in clinical trials
Rx Only Prescription required — not OTC
FDA approval status

Vyvanse approval status and regulatory context

This page is structured for LPagery Pro and uses your CSV fields to create a consistent, scalable drug-status page that matches the current DrugStatusIndex.com home page design.

What DrugStatusIndex currently shows

Vyvanse is included as a DrugStatusIndex high-priority pricing and FDA-status review entry.

Regulatory note: Users should verify labeling, approved indications, warnings, pricing, and savings terms directly through official sources before treatment decisions.
FDA status
Needs FDA status review
Drug category
High-priority pricing page candidate
Prescription status
Prescription status should be verified against current FDA labeling and pharmacy availability.
Availability note
Availability depends on prescription eligibility, pharmacy supply, insurance coverage, and current market access.

Index review fields

Review status
Needs review
Last checked
2026-05-08
Published
No
Page URL
https://drugstatusindex.com/is-vyvanse-fda-approved/
Pricing and access

Vyvanse pricing information

Pricing can vary by dose, pharmacy, insurance coverage, manufacturer savings, coupon programs, market availability, and current supply conditions.

Retail estimate
$370-$460 brand / month

Estimated cash or retail pricing range when available.

Coupon estimate
$50-$160 generic lisdexamfetamine

Discount-card or pharmacy coupon estimate when available.

Pricing last checked
May 2026

Pricing data should be rechecked before making financial or treatment decisions.

Pricing summary

Vyvanse estimated cash pricing: $370-$460 brand / month. Discount/coupon estimate: $50-$160 generic lisdexamfetamine. Pricing varies by dose, quantity, pharmacy, location, insurance, and current savings programs.

Coverage and savings notes

Manufacturer savings: Generic available; brand savings may be limited

Insurance note: Coverage varies; prior authorization common; controlled substance rules apply

Sources and verification

Verify Vyvanse directly with trusted source material

DrugStatusIndex.com is an informational resource. FDA status, availability, and pricing should be independently verified using official FDA resources, pharmacy data, prescribing information, and licensed healthcare guidance.

FDA / regulatory source
https://www.goodrx.com/lisdexamfetamine
Pricing source
https://www.goodrx.com/vyvanse | https://www.goodrx.com/lisdexamfetamine

Preview this drug-status page

Use this button to preview the generated LPagery page for Vyvanse and confirm the page output before wider publishing.

Preview Page →
Informational resource only
DrugStatusIndex.com reflects publicly available FDA regulatory data and does not provide medical advice, diagnosis, treatment recommendations, pharmacy recommendations, or legal/regulatory advice. Always consult a licensed healthcare provider before making any medical decision.
Scroll to Top